Additionally, Annexin V treatment only reduced infarct sizes and improved neurological scores 24 h after stroke in Tmem30aloxP/loxP mice, while it did not do so in Tmem30a FnKO mice (Figure 6H, I). This evidence concerns the gene ANXA5 and stroke disorder.